Eccrine angiomatous hamartoma (EAH) is a rare, benign cutaneous tumor. It is characterized by the proliferation of the eccrine gland elements that are closely associated with capillary proliferation. Patients usually present with a solitary nodule on the extremities that appeared at birth or during the prepubertal years. We report a rare case of EAH in a 13-year-old boy, with clinical features ...

The successful treatment of the rare malignancy eccrine porocarcinoma (EP) is extremely challenging, often not rewarding and when associated with metastatic disease, therapy results are disappointing. We present a unique case of treatment response of metastatic EP, with a significant disease-free interval. The patient has remained in clinical and radiological remission for 36 months since diagn...

Eccrine carcinoma is an extremely rare malignant skin cancer arising from eccrine sweat glands with a high metastatic potential. It mainly occurs in the elderly, with equal incidence in both sexes. It usually spreads to regional lymph nodes, with liver, lungs, and bones being the most common sites of distant metastasis. Because of tumor rarity, little is known about the value of F-18 FDG PET/CT...

The transforming growth factor-beta superfamily is thought to be involved in the regulation and control of growth and differentiation. These growth factors signal through transmembrane serine/threonine kinase receptors. The activation of type I receptor kinase phosphorylates a family of intracellular signalling proteins called Smads. In the present study, we wanted to localize type I and type I...

PURPOSE This study evaluates the relative frequency of benign eyelid lesions presented to a teaching hospital in Saudi population. PATIENTS AND METHODS Charts of patients with benign eyelid lesions were retrospectively reviewed from January 2003 to December 2008. Clinical details included demographic data, symptoms and signs, surgical findings, primary diagnosis, and indication for biopsy wer...

I Department of Surgical Oncology, Hospital Erasto Gaertner, Liga Paranaense de Combate ao Câncer Curitiba/PR, Brazil. II Department of Pathology Oncology, Hospital Erasto Gaertner, Liga Paranaense de Combate ao Câncer Curitiba/PR, Brazil. III Department of Skin Cancer and Melanoma, Hospital Erasto Gaertner, Liga Paranaense de Combate ao Câncer Curitiba/PR, Brazil. Email: contato@erastogaertner...